Shayan Mohammadmoradi, M.S. Ph.D
@moradishayan.bsky.social
Platelet Function & Vascular Biology @UKYMedicine | AHA Lead Scientific Communicator | CEO Moradi Enterprise | Personal Opinions | #CardioSky #MedSky
At #AHA24, the BPROAD trial: Stricter BP control saves lives! A new study shows targeting a systolic BP <120 mmHg significantly reduces CVD risk in adults with T2D compared to <140 mmHg.
www.nejm.org/doi/full/10....
#cardiosky #medsky
@ahascience.bsky.social
www.nejm.org/doi/full/10....
#cardiosky #medsky
@ahascience.bsky.social
November 18, 2024 at 8:10 PM
At #AHA24, the BPROAD trial: Stricter BP control saves lives! A new study shows targeting a systolic BP <120 mmHg significantly reduces CVD risk in adults with T2D compared to <140 mmHg.
www.nejm.org/doi/full/10....
#cardiosky #medsky
@ahascience.bsky.social
www.nejm.org/doi/full/10....
#cardiosky #medsky
@ahascience.bsky.social